Patents by Inventor Brian C. Turner

Brian C. Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEAT PAN MOUNTED MOBILE DEVICE HOLDER
    Publication number: 20240150020
    Abstract: A cabin attendant seat is disclosed. The seat may include a seat pan and a seatback. The seat may include a device holder coupled to the seat pan. The device holder may include a main body including a plurality of main body walls that define a main body cavity and a cover including a plurality of cover walls that define a cover cavity. The main body cavity and the cover cavity may form a device holder cavity configured to stow a mobile device. The device holder may include an opening configured to receive the mobile device. The device holder may include a device securing assembly configured to rotate between a first and second position, when in the first position the securing assembly configured to secure the mobile device within the cavity, when in the second position the mobile device configured to be removed from the device holder cavity.
    Type: Application
    Filed: November 9, 2022
    Publication date: May 9, 2024
    Applicant: AMI Industries, Inc.
    Inventors: Brian C. Hansen, Alexander C. Turner, Phillip J. Arellano
  • COMPOSITIONS AND METHODS FOR TREATING T CELL EXHAUSTION
    Publication number: 20220233595
    Abstract: Provided herein are compositions and methods for treating T cell exhaustion in a subject, by administering a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein) or immune cells treated with a PTD-MYC fusion protein. Kits for use in practicing the methods are also provided herein.
    Type: Application
    Filed: May 13, 2020
    Publication date: July 28, 2022
    Applicant: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Yosef REFAELI, Brian C. Turner, Thomas R. PAYNE
  • COMPOSITIONS AND METHODS FOR THE CRYOPRESERVATION OF IMMUNE CELLS
    Publication number: 20220142149
    Abstract: Provided herein are compositions and methods for the cryopreservation of immune cells, such as peripheral blood mononuclear cells (PBMCs) by pre-treating the cells with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein) prior to freezing. Kits for practicing the methods are also provided herein.
    Type: Application
    Filed: April 7, 2020
    Publication date: May 12, 2022
    Inventors: Yosef REFAELI, Brian C. TURNER, Thomas R. PAYNE
  • ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT
    Publication number: 20210177907
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Application
    Filed: February 18, 2021
    Publication date: June 17, 2021
    Inventors: Brian C. TURNER, Yosef REFAELI, Gregory Alan BIRD
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
    Publication number: 20210121550
    Abstract: Provided herein are methods and compositions for the treatment of melanoma using anti-tumor immune cells treated with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein).
    Type: Application
    Filed: November 9, 2020
    Publication date: April 29, 2021
    Inventors: Yosef REFAELI, Brian C. TURNER, Gregory Alan BIRD
  • Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
    Patent number: 10953048
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: March 23, 2021
    Assignee: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Brian C. Turner, Yosef Refaeli, Gregory Alan Bird
  • PRODUCTION AND USE OF RED BLOOD CELLS
    Publication number: 20210052655
    Abstract: The present disclosure relates to the production of red blood cells from hematopoietic stem cells, by differentiating such cells in the presence of a protein that induces cell survival and proliferation.
    Type: Application
    Filed: September 1, 2020
    Publication date: February 25, 2021
    Inventors: Brian C. TURNER, Yosef REFAELI, Gregory A. BIRD
  • Methods and compositions for the treatment of melanoma
    Patent number: 10864259
    Abstract: Provided herein are methods and compositions for the treatment of melanoma using anti-tumor immune cells treated with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein).
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: December 15, 2020
    Assignee: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Yosef Refaeli, Brian C. Turner, Gregory Alan Bird
  • Production and use of red blood cells
    Patent number: 10786534
    Abstract: The present disclosure relates to the production of red blood cells from hematopoietic stem cells, by differentiating such cells in the presence of a protein that induces cell survival and proliferation.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: September 29, 2020
    Assignee: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Brian C. Turner, Yosef Refaeli, Gregory A. Bird
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
    Publication number: 20200155600
    Abstract: Provided herein are methods for adoptive cell transfer for the treatment of cancer, comprising administering a therapeutically effective amount of immune cells having antitumor activity to a subject, wherein the immune cells are contacted with a protein transduction domain (PTD)-MYC fusion polypeptide prior to administration to the subject. In some embodiments, the PTD-MYC fusion polypeptide comprises: (i) an HIV TAT protein transduction domain; and (ii) a MYC polypeptide sequence.
    Type: Application
    Filed: August 1, 2018
    Publication date: May 21, 2020
    Inventors: Yosef REFAELI, Brian C. TURNER, Gregory Alan BIRD
  • ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT
    Publication number: 20190142870
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Application
    Filed: January 29, 2019
    Publication date: May 16, 2019
    Inventors: Brian C. TURNER, Yosef REFAELI, Gregory Alan BIRD
  • Production and use of red blood cells
    Patent number: 10272115
    Abstract: The present disclosure relates to the production of red blood cells from hematopoietic stem cells, by differentiating such cells in the presence of a protein that induces cell survival and proliferation.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: April 30, 2019
    Assignee: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Brian C. Turner, Yosef Refaeli, Gregory A. Bird
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
    Publication number: 20190060434
    Abstract: Provided herein are methods and compositions for the treatment of melanoma using anti-tumor immune cells treated with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein).
    Type: Application
    Filed: November 8, 2018
    Publication date: February 28, 2019
    Inventors: Yosef Refaeli, Brian C. Turner, Gregory Alan Bird
  • Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
    Patent number: 10206952
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: February 19, 2019
    Assignee: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Brian C. Turner, Yosef Refaeli, Gregory Alan Bird
  • Methods and compositions for the treatment of melanoma
    Patent number: 10149898
    Abstract: Provided herein are methods and compositions for the treatment of melanoma using anti-tumor immune cells treated with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein).
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: December 11, 2018
    Assignee: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Yosef Refaeli, Brian C. Turner, Gregory Alan Bird
  • PRODUCTION AND USE OF RED BLOOD CELLS
    Publication number: 20180177827
    Abstract: The present disclosure relates to the production of red blood cells from hematopoietic stem cells, by differentiating such cells in the presence of a protein that induces cell survival and proliferation.
    Type: Application
    Filed: July 6, 2017
    Publication date: June 28, 2018
    Inventors: Brian C. TURNER, Yosef REFAELI, Gregory A. BIRD
  • ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT
    Publication number: 20180117089
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Application
    Filed: October 16, 2017
    Publication date: May 3, 2018
    Inventors: Brian C. TURNER, Yosef REFAELI, Gregory Alan BIRD
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
    Publication number: 20180036396
    Abstract: Provided herein are methods and compositions for the treatment of melanoma using anti-tumor immune cells treated with a PTD-MYC fusion protein (e.g., an HIV TAT-MYC fusion protein).
    Type: Application
    Filed: August 3, 2017
    Publication date: February 8, 2018
    Inventors: Yosef REFAELI, Brian C. TURNER, Gregory Alan Bird
  • Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
    Patent number: 9789135
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: October 17, 2017
    Assignee: TAIGA BIOTECHNOLOGIES, INC.
    Inventors: Brian C. Turner, Yosef Refaeli, Gregory Alan Bird
  • ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT
    Publication number: 20150164950
    Abstract: The present disclosure relates to the acceleration of hematopoietic compartment reconstitution in a subject in need of hematopoietic stem cell transplantation by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein in combination with hematopoietic stem cell transplantation and to the enhancement of hematopoietic compartment autoreconstitution in a subject in need thereof by administering a composition having a protein transduction domain-MYC (PTD-MYC) fusion protein.
    Type: Application
    Filed: July 19, 2013
    Publication date: June 18, 2015
    Applicant: Taiga Biotechnologies, Inc.
    Inventors: Brian C. Turner, Yosef Refaeli, Gregory A. Bird